Inactive Instrument

Other languages Recipharm AB (publ)

Equities

RECI B

SE0005757267

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

Synokem Pharmaceuticals Limited acquired 74% stake in Nitin Lifesciences Limited from Recipharm AB.	Nov. 27
Recipharm Announces CEO Changes	Nov. 22
Recipharm Appoints Marc Funk as Board of Directors	Nov. 22
Recipharm Announces Executive Appointments	23-08-23
Recipharm Appoints Vikas Gupta as President of ReciBioPharm	23-05-03
RS BioTherapeutics Selects Recipharm as Product Characterization Partner	22-11-14
Recipharm AB acquired Arranta Bio Holdings, LLC from Ampersand Capital Partners and others.	22-04-10
Recipharm AB completed the acquisition of Vibalogics GmbH.	22-04-10
Recipharm AB agreed to acquire Vibalogics GmbH.	22-02-17
Recipharm AB acquired GenIBET Biopharmaceuticals, S.A.	22-01-31
Recipharm Secures Vaccine Manufacturing Deal	22-01-27
Pharmaron Beijing Co., Ltd. acquired Aesica Pharmaceuticals Limited from Recipharm AB.	22-01-09
Samsung Biologics : Eurazeo prépare une vente du groupe pharmaceutique Seqens, selon des sources	21-02-08
Recipharm : 2020 Profit In Line With Prior Year as Financial Expenses Offset Higher Sales	21-01-28
EN DIRECT DES MARCHES : STMicroelectronics, Elior, TechnipFMC, Valneva, Apple, Tesla, BMW, EasyJet...	21-01-28
Recipharm AB Publ Reports Earnings Results for the Fourth Quarter Ended December 31, 2020	21-01-28
La bourse reste hermétique au déclin de Trump	21-01-11
AVIS D'ANALYSTES DU JOUR : Air Liquide, Airbus, Aperam, Fresenius, LafargeHolcim, Saint-Gobain, Straumann...	21-01-11
Pas de Brexit, pas de plan US, mais des vaccins	20-12-14
EN DIRECT DES MARCHES : Vivendi, Danone, Solutions 30, Vallourec, Gaussin, Alexion, Codemasters, Oracle, Ferrari	20-12-14

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Recipharm AB (publ)

Equities

RECI B

SE0005757267

Other languages

Filters